Tower Cold Chain Expands to American Center of Excellence
Tower Cold Chain will soon open its new headquarters in Philadelphia.
Tower Cold Chain, a pharmaceutical thermal protection specialist, has completed its new headquarters in the Americas region, it announced on June 27, 2023. The facility will officially open on Sept. 12, 2023, according to a company press release.
The building, located in Philadelphia, Pa., is the latest facility offering design, laboratory, and testing capabilities in the development of its temperature-controlled solutions. Further, Tower Cold Chain hopes this expansion will serve as a hub of innovation and expertise and a place for stronger partnerships to develop in the cold chain logistics industry.
“We are thrilled to inaugurate our Cent[er] of Excellence in Philadelphia, which demonstrates our unwavering commitment to the Americas market,” said Niall Balfour, chief executive officer, Tower Cold Chain, in the press release. “This marks a significant step in Tower’s growth trajectory. As demand for robust, reliable, reusable pharmaceutical logistics continues to surge, our investment in strategic locations enables us to provide essential support for the seamless transportation of temperature-sensitive pharmaceutical and life-science products.”
Source: Tower Cold Chain
EMA Recommends Imfinzi-Based Perioperative Regimen for Treating Resectable NSCLC
March 10th 2025The committee’s recommendation is based on results from a Phase III trial in which Imfinzi demonstrated a reduced risk of recurrence, progression, or death by 32% compared to neoadjuvant chemotherapy alone.
International Women’s Day 2025: A Promising Future for Gender Diversity in Pharma
March 8th 2025In an interview with BioPharm International®, Sheryl Johnson from Orbia Fluor & Energy Materials chats about gender diversity, how women are helping to advance innovation, sustainability challenges, and progress in the field of inhaled drugs.
